• August 13, 2012
    NEW YORK--Pfizer Inc. (NYSE: PFE) today announced that its subsidiary, Zoetis™ Inc. (zō-EH-tis), filed a registration statement with the U.S. Securities and Exchange Commission for a potential initial public offering (IPO) of Class A common stock. The offering is expected to represent an ownership stake of up to 20 percent. Prior to completion of the offering, which is targeted for the first half of 2013, Pfizer will transfer its animal healthmore...
  • June 7, 2012
    NEW YORK--Pfizer Inc. (NYSE: PFE) today announced the next steps in the strategic alternatives review process for the company's Animal Health business. Preparations are underway to file a registration statement in the U.S. for a potential initial public offering (IPO) of a minority ownership stake in the new company. Pfizer expects to provide details regarding the proposed transaction as part of its 2012 second quarter earnings announcement.more...
  • April 13, 2012
    PARIS, France--Four European academic research groups, together with Pfizer Animal Health, have forged a new research consortium to combat uterine disease - a problem that costs the EU dairy industry about €1.4billion annually. Called the IPUD research project (Integrated systems approach for Preventing Uterine Disease in dairy cattle), the collaboration involves academic research groups at Swansea University, the University ofmore...
  • March 29, 2012
    LONDON, England--The Chinese Veterinary Medical Association (CVMA) and the International Veterinary Collaboration for China (IVCC), a consortium of leading veterinary medical schools in the United States and United Kingdom and Pfizer Animal Health, announced the signing of a memorandum of understanding through which the CVMA will collaborate with the IVCC to advance veterinary medical education and animal health in mainland Chinamore...
  • November 8, 2011
    KALAMAZOO, Mich.--Pfizer Animal Health affirmed its commitment to innovation in equine health with the opening today of the Pfizer Animal Health Equine Research Center in Richland, Mich. The center, the culmination of a $7 million investment, expands Pfizer Animal Health’s global research and development network headquarters in Kalamazoo, Mich., and will serve as the worldwide hub for research and development of equine vaccines and novelmore...
  • November 3, 2011
    JILIN--Pfizer Animal Health, a business unit of Pfizer (NYSE: PFE), and Jilin Guoyuan Animal Health Co., Ltd., announced today the establishment of the joint venture Jilin Pfizer Guoyuan Animal Health Co., Ltd. The joint venture, which has been granted a license by local Chinese government authorities, formalizes the strategic agreement signed on September 8 to develop, manufacture, and distribute animal vaccines in China. Terms of the agreementmore...
  • October 18, 2011
      NEW YORK, N.Y., October 18 - Pfizer Animal Health and The Resource Foundation announced today the expansion of a comprehensive education and training program to increase the capacity, productivity and quality of life of rural farmers in eight Latin American countries.  Plans call for tailoring the program to the needs of rural communities in India.  The agreement was guided by results of a decade-long collaboration also announced today.  Pfizer Animal Health and themore...
  • October 13, 2011
    MADISON, N.J.--Five livestock veterinarians and about 20 of their client farms in four states volunteered to be filmed for a new reality series, to give consumers a personal and up-close view of responsible livestock farming in the U.S. The series, “Veterinarians on Call,” captures the pride and responsibility of veterinarians in their day-to-day work on U.S. farms and ranches, working with their client livestock farmers and othermore...
  • September 8, 2011
    MADISON, N.J., & HUINAN, China--Pfizer Animal Health, a business unit of Pfizer Inc. (NYSE: PFE), and Jilin Guoyuan Animal Health Company, Ltd., an innovator in animal health vaccines based in Huinan, today announced an agreement to jointly develop, manufacture and distribute animal health vaccines in China. The new joint venture, Jilin Pfizer Guoyuan Animal Health Co., Ltd., will bolster the capabilities of both companies to offer amore...
  • July 7, 2011
    NEW YORK--Pfizer Inc. (NYSE: PFE) today announced that it is exploring strategic alternatives for its Animal Health and Nutrition businesses based on its recent business portfolio review to determine the optimal mix of businesses for maximizing shareholder value. The company is considering options that may include, among others, a full or partial separation of each of these businesses from Pfizer through a spin-off, sale or other transaction.more...